Key result
Physicians rarely initiate discussions about ICD deactivation at the end of life due to the device's small internal nature, its primary life-saving role, lack of established patient rapport, and general concerns about withdrawing care.
Why the study?
What are the barriers preventing physicians from discussing the deactivation of implantable cardioverter defibrillators at the end of life?
Population
12 physicians from 3 states
Design
Other
Authors
Loading...
Barriers to end-of-life ICD deactivation discussions warrant clinician awareness; leaves open whether targeted education improves communication practices.
What are the barriers preventing physicians from discussing the deactivation of implantable cardioverter defibrillators at the end of life?
ICDs possess unique characteristics that make end-of-life deactivation discussions difficult for physicians, highlighting a need for targeted educational interventions.
Goldstein et al. (2007) studied Physicians managing patients with Implantable Cardioverter Defibrillators (ICDs) at the end of life (n=12). Discussions about ICD deactivation was evaluated on Barriers to physician-initiated discussions about ICD deactivation. Physicians rarely initiate discussions about ICD deactivation at the end of life due to the device's small internal nature, its primary life-saving role, lack of established patient rapport, and general concerns about withdrawing care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: